The global peptide synthesis market involves the production of short chains of amino acids called peptides, through either chemical or biological methods. Peptides find application in pharmaceutical and biotechnological research due to their ability to block or stimulate cell receptors, making them promising drug candidates. Key advantages of peptides include high target specificity, minimal toxicity and side effects. The rising demand for peptide-based drugs and diagnostics tools is driving immense investments in the development of new and cost-effective peptide synthesis techniques.
The Global Peptide Synthesis Market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 To 2031.
Key Takeaways
Key players: Key players operating in the peptide synthesis market are GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth.
Growing demand: The rising incidence of chronic diseases and growing demand for peptide-based drugs is a major factor Peptide Synthesis Market Trends Also, increasing R&D investment by pharmaceutical and biotech companies is contributing to market growth.
Global expansion: Leading manufacturers are focusing on expanding their global footprint through acquisitions and partnerships to cater to the growing demand for peptide synthesis instruments and reagents across worldwide.
Market key trends
The Peptide Synthesis Market Size And Trends is witnessing a rising trend of automation with the introduction of advanced technologies such as automated peptide synthesizers to accelerate production rates while maintaining high purity levels. These automated synthesizers reduce production time and labor costs significantly. Growing demand for customized peptides is another key trend with companies offering rapid custom peptide synthesis services to meet client-specific requirements.
Porter's Analysis
Threat of new entrants: High capital requirements for equipment and expertise pose a barrier.
Bargaining power of buyers: Customers can choose from multiple companies due to commoditization of standard peptides.
Bargaining power of suppliers: Dependence on few suppliers of raw materials maintains prices.
Threat of new substitutes: Limited threat due to specialized applications and complex synthesis process.
Competitive rivalry: Intense competition among major players to expand market share through innovation.
Geographical Regions
North America currently holds the largest share of the peptide synthesis market in terms of value due to established biopharmaceutical industry and presence of major players in the US and Canada. The Asia Pacific region is expected to witness the fastest growth over the forecast period supported by increasing research funding and growing clinical trials in China, Japan and India.
Comments
0 comment